Product Name: DuoDote™ Auto-Injector1 Mark I™ Kit 2,3

Slides:



Advertisements
Similar presentations
Emergency Management of Nerve Agent Casualties
Advertisements

UNDERSTANDING ANAPHYLAXIS
Use of Auto-Injectors by Civilian Emergency Medical Personnel to Treat Civilians Exposed to Nerve Agent © © 1997 Lockheed Martin Energy Research Corporation.
San Mateo Union High School District Fall Semester, 2003
Omaha Metropolitan Medical Response System OMMRS Administration of Mark I™ Kit, DuoDote™ and AtroPen® Auto-Injectors Presented by the OMMRS Pharmacy.
Nerve agents & Mark 1 Auto injectors
Viewgraph 1 Nerve Agent Antidote Kit, MARK I. Viewgraph 2 Holding MARK I (NAAK)
IM Epinephrine Administration by the EMT
Allergy Awareness & EpiPen ® Use. Common food allergies in children Milk Egg Peanut Tree Nuts Shellfish Fish Soy Whey.
 Tree Nuts  Milk  Egg  Peanut  Bananas  Pollen  Soy  Shellfish  Latex  Fish  Wheat  Animal Dander.
NERVE AGENTS & PRETREAMENT
Anaphylaxis EpiPen Training. A potentially life-threatening severe allergic reaction to a substance.
To go to next slide click mouse. There must be disposable gloves in each classroom. Universal Precautions’ signs must be posted in a visible place in.
Anaphylaxis=Killer Allergy ☻ Who is at risk? Anyone, especially those allergic to food such as peanuts, tree nut, seafood, fish, milk or egg, or to insect.
 Tree Nuts  Milk  Egg  Peanut  Bananas  Pollen  Soy  Shellfish  Latex  Fish  Wheat  Animal Dander.
Any delegate administering an EpiPen injection must receive child specific training. The delegate must be willing to assume the responsibility. The delegate.
EpiPen Administration
Care for Students with Severe Allergies. Anaphylaxis: Definition and Interesting Facts Anaphylaxis: –Is a rapid, severe allergic response –Is not always.
Save a Life with Epinephrine - EpiPen®
Epipen In-Service. Purpose: The purpose of the Epipen is to administer a pre-measured dose of Epinephrine to patient with qualifying conditions.
Helping Belton ISD Students Succeed What Every BISD Staff Needs to Know About: Helping Belton ISD Students Succeed What Every BISD Staff Needs to Know.
Food Allergies and Allergic Reactions When and How to Use an Epi-Pen.
Required when distributed (EMR, EMT, AEMT). Objectives At the completion of this education module, the provider will have: An understanding of scene safety.
Medication Administration. Medications Epinephrine (Epi-Pen) Albuterol (MDI) Atropine/2-PAM (Mark-1 Kit) Oral Glucose Oxygen.
WTF!!!! Lol BY Angel Chavez & Miguel Resendiz. What the F*** is it?  Chlorfenvinphos is a Organophosphorus compound.  Organophosphorus is of, relating.
Triage Tag Construction n Synthetic paper – Water resistant n 100 % resistant to all commonly used decontamination solutions – May be worn while patient.
Nerve Agent Antidote Kit Training Objectives:
Nerve Agents: Recognition and Treatment Ventura County Emergency Medical Services.
Maryland State MARK I Training Program Nerve Agents and the MARK I Kits.
1 Module 4 Signs and Symptoms. 2 Situation Assessment Known information regarding the chemical release Recognition of the event based on signs and symptoms.
Nerve Agent Antidote Kit
ATROPINE ONLY Initial, on scene, treatment by EMS for Nerve Agent or Organophosphate poisoning in the absence of Mark 1 kits.
Module 7 Medical Treatment
Making a Case for Hospital Decontamination -A Community Issue- Presented by: Jan Glarum.
FCDPH ANAPHYLAXIS. Anaphylaxis (pronounced ana-fill-axis) is a serious allergic reaction that is rapid in onset and may cause death. FCDPH Retrieved from:
Chapter 35 Poisoning and Allergic Reactions. © 2005 by Thomson Delmar Learning,a part of The Thomson Corporation. All Rights Reserved 2 Overview  Poisoning.
Limmer et al., Emergency Care, 10 th Edition © 2005 by Pearson Education, Inc. Upper Saddle River, NJ CHAPTER 20 Allergic Reactions.
EPI PEN Training. WHAT IS A FOOD ALLERGY? Over-Reaction in the body to a food Release of chemical called HISTAMINE Triggers reactions in body.
To insert your company logo on this slide From the Insert Menu Select “Picture” Locate your logo file Click OK To resize the logo Click anywhere inside.
Anaphylactic Allergies  Common Causes  Foods (peanuts, tree nuts, seafood)  Insect stings.
Anaphylaxis in Schools
Anaphylaxis in Schools Recognizing Anaphylaxis Epinephrine Auto-injector Administration Betsy Stoffers RN 2014.
CMT Training The Center for Life Enrichment Resource: MTTP Student Manual,
South Bay Disaster Resource Center at Harbor-UCLA Medical Center Nerve Agents & MARK 1 Antidote Administration.
Anaphylaxis Caring for Children in a Community Program
First Aid for Shock By: Shayla Z. Matt S. Sara K. Allen M.
Chapter 19: Terrorism Awareness. Knowledge and Attitude Objectives 1.Define terrorism. 2.Describe potential terrorist targets and risks. 3.Explain the.
© 1999 Lockheed Martin Energy Research Corporation CA128 NERVE AGENT EXPOSURE.
Assisting Students With Severe Allergies: Epinephrine Auto-injector Training Instructor’s Name: Myra Pickard, RN BSN, NCSN.
Sarin Serene Selli & Hannah Pritchard 7 th Period.
1 Click here to continue 2 Directions: This is a self-paced course on the use of a MK1 Kit after exposure to GB nerve agent. Proceed through the course.
Omaha Metropolitan Medical Response System OMMRS Mark I Kit Training for Health Care Professionals © Presented by the OMMRS Pharmacy Subcommittee.
Is this a problem at school?
PERFORM FIRST AID FOR NERVE AGENT INJURY 1.
August 2005 EMS & Trauma Systems Section Office of Public Health Preparedness CHEMICAL AGENTS.
NERVE AGENTS. DEFINITION  A substance that causes biological effects by inhibiting acetylcholinesterase  Acetylcholine accumulates  Effects are due.
Protecting those who protect us
Welcome to Epi-pen and Glucagon Training
Epi-Pen Training for Non-Licensed Staff
How to treat organophosphate poisoning (Nerve agent/insecticide)
Covington County Schools Michelle Armstrong, RN
Use of Auto-Injectors by Civilian Emergency Medical Personnel to Treat Civilians Exposed to Nerve Agent© © 1997 Lockheed Martin Energy Research Corporation.
Use of Auto-Injectors by Civilian Emergency Medical Personnel to Treat Civilians Exposed to Nerve Agent© OEMS Approval # for 2007:  (2 hours)
NERVE AGENT EXPOSURE CA128.
Anaphylaxis & EpiPen Administration
Epinephrine is the treatment of choice for allergic reactions……
C MODULE: EpiPen.
Lesson 22 ADMINISTER FIRST AID TO CHEMICAL AGENT CASUALTIES
LESSON 13 ADMINISTER FIRST AID TO A NERVE AGENT CASUALTY
Emergency Medical Services Program
Presentation transcript:

Guidelines and Injection Instructions for DuoDote™ Auto-Injector

DuoDote™ Has Replaced the Mark I™ Kit Delivers the same protection in a single auto-injector Product Name: DuoDote™ Auto-Injector1 Mark I™ Kit 2,3 Active Ingredients: 2.1 mg atropine 600 mg pralidoxime chloride 2 mg atropine Delivery Mechanism: 1 auto-injector featuring dual-chamber technology 2 auto-injectors, each with a single traditional chamber Steps to Administer: Simple administration with just 1 injection Additional steps required – 2 separate injections Overall Dimensions: 6” x 1” x 1” 6” x 1.5” x 1” Shelf Life: 4 years 5 years Packaging: Chemically hardened pouch Foam pouch

What Is DuoDote™? Developed by Meridian Medical Technologies™ as a streamlined, easy-to-use replacement for the Mark I™ Kit FDA approved for Emergency Medical Services (EMS) use in the treatment of organophosphorus nerve agent and organophosphorus insecticide poisoning1 Approved by MIEMSS for our use Contains two antidotes in 1 auto-injector 2.1 mg of atropine in a 0.7-mL solution 600 mg of pralidoxime chloride in a 2-mL solution Features next-generation BinaJect™ delivery technology 2 antidotes delivered sequentially into separate areas of the muscle Easy to use: only 1 injection with 1 needle

What Is DuoDote™? (contd) Indications The DuoDote™ Auto-Injector (atropine and pralidoxime chloride injection) is indicated for the treatment of poisoning by organophosphorus nerve agents as well as organophosphorus insecticides The DuoDote™ Auto-Injector should be administered by Emergency Medical Services personnel who have had adequate training in the recognition and treatment of nerve agent or insecticide intoxication The DuoDote™ Auto-Injector is intended as an initial treatment of the symptoms of organophosphorus insecticide or nerve agent poisoning; definitive medical care should be sought immediately The DuoDote™ Auto-Injector should be administered as soon as symptoms of organophosphorus poisoning appear

Organophosphorus Poisoning: What Are the Symptoms? Mild symptoms4,5 Blurred vision, miosis (excessive constriction of the pupils) Excessive, unexplained teary eyes Excessive, unexplained runny nose Increased salivation such as sudden drooling Chest tightness or difficulty breathing Tremors throughout the body or muscular twitching Nausea and/or vomiting Unexplained wheezing, coughing, or increased airway secretions Acute onset of stomach cramps Tachycardia or bradycardia (abnormally fast or slow heartbeat)

Organophosphorus Poisoning: What Are the Symptoms? (contd) Severe symptoms4,5 Strange or confused behavior Severe difficulty breathing or copious secretions from lungs/airway Severe muscular twitching and general weakness Involuntary urination and defecation Convulsions Loss of consciousness Respiratory arrest (possibly leading to death)

Organophosphorus Poisoning: What Are the Symptoms? (contd) A quick-reference mnemonic for use in the field is OBSERVE Others affected suddenly Body tremors/twitching Salivation Eye tearing Restricted breathing Vomiting Excessive sweating

Guidelines for Administering DuoDote™1 For mild symptoms of organophosphorus poisoning FIRST DOSE: In the situation of known or suspected organophosphorus poisoning, administer one DuoDote™ injection into the mid-outer thigh if the patient experiences two or more MILD symptoms of nerve gas or insecticide exposure1 EMS with mild symptoms may self-administer a single dose of DuoDote™ Wait 10 to 15 minutes for DuoDote™ to take effect. If, after 10 to 15 minutes, the patient does not develop any SEVERE symptoms, no additional DuoDote™ injections are recommended, but definitive medical care should ordinarily be sought immediately. For EMS personnel who have self-administered DuoDote™, an individual decision will need to be made to determine their capacity to continue to provide emergency care ADDITIONAL DOSES: If, at any time after the first dose, the patient develops any SEVERE symptoms, administer two additional DuoDote™ injections in rapid succession, and immediately seek definitive medical care1

Guidelines for Administering DuoDote™1 (contd) For severe symptoms of organophosphorus poisoning If a patient has any SEVERE symptoms of organophosphorus poisoning, immediately administer three DuoDote™ injections into the patient’s mid-outer thigh in rapid succession,1 and immediately seek definitive medical carea No more than 3 doses of DuoDote™ should be administered unless definitive medical care (eg, hospitalization, respiratory support) is available1 Emergency care of the severely poisoned individual should include removal of oral and bronchial secretions, maintenance of a patent airway, supplemental oxygen, and, if necessary, artificial ventilation An anticonvulsant, such as diazepam,6 may be administered to treat convulsions if suspected in the unconscious individual.b The effects of nerve agents and some insecticides can mask the motor signs of a seizure Close supervision of all severely poisoned patients is indicated for at least 48 to 72 hours a Limit of 3 doses is specific to the pralidoxime component of DuoDote™. If necessary, additional doses of AtroPen® Auto-Injector (atropine) can be administered if the 3 doses of DuoDote™ do not produce an adequate response.2 b Diazepam is recommended in addition to DuoDote™ if symptoms include convulsions. Please see full Prescribing Information for Diazepam Auto-Injector (C-IV).6 [http://www.meridianmeds.com/pdf/Diazepam_Pack_Insert.pdf]

DuoDote™ Injection Instructions1 Before injecting Tear open plastic pouch at any of the notches, and remove the DuoDote™ Auto-Injector Place DuoDote™ in your dominant hand and firmly grasp it, with the Green Tip pointing downward With your other hand, pull off the Gray Safety Release, taking care never to touch the Green Tip Keep fingers clear of both ends of the auto-injector You are now ready to inject

DuoDote™ Injection Instructions1 (contd) Select site and inject The injection site is the mid-outer thigh area. You can inject through clothing, but make sure that pockets are empty Swing and firmly push Green Tip straight down (at a 90º angle) against mid-outer thigh, continuing to push firmly until you feel the auto-injector trigger After the DuoDote™ Auto-Injector triggers, hold it firmly in place against the injection site for 10 seconds

DuoDote™ Injection Instructions1 (contd) After injecting Remove the DuoDote™ Auto-Injector from thigh and inspect the Green Tip; if the needle is visible, then the injection was successful If the needle is not visible, make sure the Gray Safety Release is removed and repeat the preceding injection steps Push the exposed needle against a hard surface until it bends back, then put the used auto-injector back in the plastic pouch Keep used auto-injector(s) with the patient so other medical personnel will be aware of how many injections were administered Immediately move away from the contaminated area, decontaminate skin and clothing, and seek definitive medical treatment

Back of Tag DuoDote™ Injection Instructions1 (contd) If using the MIEMSS Triage Tag, consider applying a bar code to each DuoDote administered. Document the times administered on the back of the Triage Tag. Back of Tag

Additional Information Contact the On-Duty EMS Duty Officer or EMS Medical Director

Important Safety Information The DuoDote™ Auto-Injector is intended as an initial treatment of the symptoms of organophosphorus insecticide or nerve agent poisonings; definitive medical care should be sought immediately. The DuoDote™ Auto-Injector should be administered by EMS personnel who have had adequate training in the recognition and treatment of nerve agent or insecticide intoxication. Individuals should not rely solely upon agents such as atropine and pralidoxime to provide complete protection from chemical nerve agents and insecticide poisoning. Primary protection against exposure to chemical nerve agents and insecticide poisoning is the wearing of protective garments, including masks designed specifically for this use. Evacuation and decontamination procedures should be undertaken as soon as possible. Medical Personnel assisting evacuated victims of nerve agent poisoning should avoid contaminating themselves by exposure to the victim’s clothing. In the presence of life-threatening poisoning by organophosphorus nerve agents or insecticides, there are no absolute contraindications to the use of the DuoDote™ Auto-Injector. When symptoms of poisoning are not severe, DuoDote™ Auto-Injector should be used with extreme caution in people with heart disease, arrhythmias, recent myocardial infarction, severe narrow angle glaucoma, pyloric stenosis, prostatic hypertrophy, significant renal insufficiency, chronic pulmonary disease, or hypersensitivity to any component of the product. PLEASE CLICK HERE TO VIEW FULL PRESCRIBING INFORMATION. [ http://www.meridianmeds.com/pdf/Duodote_Pack_Insert.pdf ] or click here to launch accompanying Acrobat PDF document

For More Information To request additional educational materials, or to order DuoDote™, please contact Meridian Medical Technologies™ Via toll free call at 1-800-638-8093 Via e-mail at customerservice@meridianmt.com On the Web at www.DuoDote.com DuoDote Auto-Injector, the DuoDote Logo, Mark I Kit, and BinaJect are trademarks of Meridian Medical Technologies™, Inc., a wholly owned subsidiary of King Pharmaceuticals®, Inc. Copyright © 2009 Meridian Medical Technologies™, Inc., a wholly owned subsidiary of King Pharmaceuticals®, Inc. All rights reserved. MMT6153 06/2009 ™ References: 1. DuoDote Auto-Injector [package insert]. Columbia, MD: Meridian Medical Technologies, Inc; 2007. http://www.meridianmeds.com/pdf/Duodote_Pack_Insert.pdf. Accessed September 7, 2007. 2. AtroPen Auto-Injector [package insert]. Columbia, MD: Meridian Medical Technologies, Inc; 2007. http://www.meridianmeds.com/pdf/AtroPen_Pack_Insert.pdf. Accessed September 7, 2007. 3. Pralidoxime Chloride Injection (Auto-Injector) [package insert]. Columbia, MD: Meridian Medical Technologies, Inc; 2007. http://www.meridianmeds.com/pdf/2Pam_Cl_Pack_Insert.pdf. Accessed September 7, 2007. 4. Sidell FR. Nerve agents. In: Sidell FR,Takafuji ET, Franz DR, eds. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of The Surgeon General at TMM Publications Borden Institute; 1997:129-181. 5. Agency for Toxic Substances and Disease Registry. Medical Management Guidelines (MMGs) for nerve agents: tabun (GA); sarin (GB); soman (GD); and VX. http://www.atsdr.cdc.gov/MHMI/mmg166.html. Accessed September 7, 2007. 6. Diazepam Auto-Injector (C-IV) [package insert]. Columbia, MD: Meridian Medical Technologies, Inc; 2007. http://www.meridianmeds.com/pdf/Diazepam_Pack_Insert.pdf. Accessed September 7, 2007.